India Xerostomia Therapeutics Market - Industry Trends and Forecast to 2030

List of Tables

The India xerostomia therapeutics market is expected to reach USD 25.20 million by 2030 from USD 16.97 million in 2022, growing at a CAGR of 5.1% during the forecast period of 2023 to 2030.

Market Segmentation

India Xerostomia Therapeutics Market, By Product Type (Saliva Substitutes, Drugs, Salivary Pen, and Others), Type (True Xerostomia and Pseudo Xerostomia Or Symptomatic Xerostomia), Mode of Purchase (Prescription (Rx) and Over The Counter (OTC)), Population (Geriatric and Adults), End User (Dental Clinics, Hospitals, Specialty Clinics, and Home Care), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Online Sales) - Industry Trends and Forecast to 2030.

Overview of India Xerostomia Therapeutics Market Dynamics

Driver
Advancements in pharmaceutical research and development
Restraint
High cost associated with xerostomia treatment
Opportunity
Rising product collaborations and partnerships

Market Players

Some of the major market players operating in the India xerostomia therapeutics market are:

Colgate-Palmolive Company
Sun Pharmaceutical Industries Ltd.
Haleon Group of Companies
3M
Alish Life Saving Impex Private Limited
GC India Dental
ICPA Health Products Ltd
Saliwell Ltd.

1 INTRODUCTION 12

1.1 OBJECTIVES OF THE STUDY 12
1.2 MARKET DEFINITION 12
1.3 OVERVIEW OF THE INDIA XEROSTOMIA THERAPEUTICS MARKET 12
1.4 LIMITATIONS 13
1.5 MARKETS COVERED 14

2 MARKET SEGMENTATION 16

2.1 MARKETS COVERED 16
2.2 GEOGRAPHICAL SCOPE 17
2.3 YEARS CONSIDERED FOR THE STUDY 17
2.4 CURRENCY AND PRICING 17
2.5 DBMR TRIPOD DATA VALIDATION MODEL 18
2.6 MULTIVARIATE MODELLING 21
2.7 STAGES LIFELINE CURVE 21
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 22
2.9 DBMR MARKET POSITION GRID 23
2.10 MARKET END USER COVERAGE GRID 24
2.11 VENDOR SHARE ANALYSIS 25
2.12 SECONDARY SOURCES 26
2.13 ASSUMPTIONS 26

3 EXECUTIVE SUMMARY 27

4 PREMIUM INSIGHTS 29

4.1 PESTEL'S MODEL 30
4.2 PORTER'S 5 FORCES 31
4.3 GROWTH STRATEGIES ADOPTED BY THE KEY MARKET PLAYERS 32

5 EPIDEMIOLOGY 33

6 PIPELINE ANALYSIS 34

7 INDIA XEROSTOMIA THERAPEUTICS MARKET, REGULATIONS 35

8 MARKET OVERVIEW 37

8.1 DRIVERS 39
- 8.1.1 RISING USE OF CHEMOTHERAPY AND RADIOTHERAPY IN THE CANCER TREATMENT 39
- 8.1.2 GROWING PREVALENCE OF XEROSTOMIA 39
- 8.1.3 ADVANCEMENTS IN THE PHARMACEUTICAL RESEARCH AND DEVELOPMENT 40
- 8.1.4 INCREASING USAGE OF PRESCRIPTION MEDICINES 41
8.2 RESTRAINTS 41
- 8.2.1 HIGH COST ASSOCIATED WITH XEROSTOMIA TREATMENT 41
- 8.2.2 SIDE EFFECTS ASSOCIATED WITH XEROSTOMIA THERAPIES 42
8.3 OPPORTUNITIES 42
- 8.3.1 RISING PRODUCT COLLABORATIONS AND PARTNERSHIPS 42
- 8.3.2 RISING RESEARCH AND DEVELOPMENT ACTIVITIES FOR THE DEVELOPMENT OF NOVEL THERAPIES 43
8.4 CHALLENGES 43
- 8.4.1 LACK OF AWARENESS OF XEROSTOMIA 43
- 8.4.2 LACK OF TREATMENTS AVAILABLE FOR XEROSTOMIA 44

9 INDIA XEROSTOMIA THERAPEUTICS MARKET, BY PRODUCT TYPE 45

9.1 OVERVIEW 46
9.2 SALIVA SUBSTITUTES 49
- 9.2.1 MOUTHWASH 50
- 9.2.2 TOOTHPASTE 50
- 9.2.3 DENTIFRICES 50
- 9.2.4 ARTIFICIAL SALIVA 50
  - 9.2.4.1 ORAL SOLUTION 52
    - 9.2.4.1.1 ORAL SPRAY 52
    - 9.2.4.1.2 ORAL RINSE 52
    - 9.2.4.1.3 OTHERS 52
  - 9.2.4.2 GEL 52
  - 9.2.4.3 LOZENGE 53
  - 9.2.4.4 DISSOLVING TABLETS 53
  - 9.2.4.5 SWABS 53
  - 9.2.4.6 POWDER 53
  - 9.2.4.7 AQUORAL 54
  - 9.2.4.8 SALIVASURE 54
  - 9.2.4.9 OASIS 54
  - 9.2.4.10 CAPHOSOL 54
  - 9.2.4.11 XYLIMELTS 54
  - 9.2.4.12 OTHERS 54
- 9.2.5 OIL-BASED SALIVA SUBSTITUTES 54
- 9.2.6 SALIVARY STIMULANTS 54
- 9.2.7 CHEWING GUMS 55
9.3 DRUGS 55
- 9.3.1 CHOLINOMIMETIC DRUGS 56
  - 9.3.1.1 PILOCARPINE 56
  - 9.3.1.2 CEVIMELINE 56
  - 9.3.1.3 ANETHOLETRITHIONE 56
- 9.3.2 YOHIMBINE 56
- 9.3.3 OTHERS 57
- 9.3.4 BRANDED 57
- 9.3.5 SIALOR 58
- 9.3.6 PILOCARPINE 58
- 9.3.7 SALAGEN 58
- 9.3.8 EXOVAC 58
- 9.3.9 OTHERS 58
- 9.3.10 GENERIC 58
9.4 SALIVARY PEN 58
9.5 OTHER 59

10 INDIA XEROSTOMIA THERAPEUTICS MARKET, BY TYPE 60

10.1 OVERVIEW 61
10.2 TRUE XEROSTOMIA 64
10.3 PSEUDO XEROSTOMIA OR SYMPTOMATIC XEROSTOMIA 64

11 INDIA XEROSTOMIA THERAPEUTICS MARKET, BY MODE OF PURCHASE 65

11.1 OVERVIEW 66
11.2 PRESCRIPTION (RX) 69
11.3 OVER THE COUNTER (OTC) 69

12 INDIA XEROSTOMIA THERAPEUTICS MARKET, BY POPULATION TYPE 70

12.1 OVERVIEW 71
12.2 GERIATRIC 74
12.3 ADULTS 74

13 INDIA XEROSTOMIA THERAPEUTICS MARKET, BY END USER 75

13.1 OVERVIEW 76
13.2 DENTAL CLINICS 79
13.3 HOSPITALS 79
13.4 SPECIALTY CLINICS 80
13.5 HOME CARE 80

14 INDIA XEROSTOMIA THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL 81

14.1 OVERVIEW 82
14.2 RETAIL PHARMACIES 85
14.3 HOSPITAL PHARMACIES 85
14.4 ONLINE SALES 86

15 INDIA XEROSTOMIA THERAPEUTICS MARKET: COMPANY LANDSCAPE 87

15.1 COMPANY SHARE ANALYSIS: INDIA 87

16 SWOT ANALYSIS 88

17 COMPANY PROFILE 89

17.1 COLGATE-PALMOLIVE COMPANY. 89
- 17.1.1 COMPANY SNAPSHOT 89
- 17.1.2 REVENUE ANALYSIS 89
- 17.1.3 PRODUCT PORTFOLIO 90
- 17.1.4 RECENT DEVELOPMENTS 90
17.2 SUN PHARMACEUTICAL INDUSTRIES LTD. 91
- 17.2.1 COMPANY SNAPSHOT 91
- 17.2.2 REVENUE ANALYSIS 91
- 17.2.3 PRODUCT PORTFOLIO 92
- 17.2.4 RECENT DEVELOPMENTS 92
17.3 HALEON GROUP OF COMPANIES. 93
- 17.3.1 COMPANY SNAPSHOT 93
- 17.3.2 REVENUE ANALYSIS 93
- 17.3.3 PRODUCT PORTFOLIO 94
- 17.3.4 RECENT DEVELOPMENTS 94
17.4 3M 95
- 17.4.1 COMPANY SNAPSHOT 95
- 17.4.2 REVENUE ANALYSIS 95
- 17.4.3 PRODUCT PORTFOLIO 96
- 17.4.4 RECENT DEVELOPMENTS 96
17.5 ALISH LIFE SAVING IMPEX PRIVATE LIMITED. 97
- 17.5.1 COMPANY SNAPSHOT 97
- 17.5.2 PRODUCT PORTFOLIO 97
- 17.5.3 RECENT DEVELOPMENT 97
17.6 GC CORPORATION. 98
- 17.6.1 COMPANY SNAPSHOT 98
- 17.6.2 PRODUCT PORTFOLIO 98
- 17.6.3 RECENT DEVELOPMENT 98
17.7 ICPA HEALTH PRODUCTS LTD 99
- 17.7.1 COMPANY SNAPSHOT 99
- 17.7.2 PRODUCT PORTFOLIO 99
- 17.7.3 RECENT DEVELOPMENT 99
17.8 SALIWELL LTD. 100
- 17.8.1 COMPANY SNAPSHOT 100
- 17.8.2 PRODUCT PORTFOLIO 100
- 17.8.3 RECENT DEVELOPMENT 100

18 QUESTIONNAIRE 101

19 RELATED REPORTS 104

LIST OF TABLES

TABLE 1 INDIA XEROSTOMIA THERAPEUTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 48
TABLE 2 INDIA XEROSTOMIA THERAPEUTICS MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 48
TABLE 3 INDIA SALIVA SUBSTITUTES IN XEROSTOMIA THERAPEUTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 49
TABLE 4 INDIA SALIVA SUBSTITUTES IN XEROSTOMIA THERAPEUTICS MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 50
TABLE 5 INDIA ARTIFICIAL SALIVA IN XEROSTOMIA THERAPEUTICS MARKET, BY FORM, 2021-2030 (USD MILLION) 51
TABLE 6 INDIA ARTIFICIAL SALIVA IN XEROSTOMIA THERAPEUTICS MARKET, BY FORM, 2021-2030 (VOLUME) 51
TABLE 7 INDIA ORAL SOLUTION IN XEROSTOMIA THERAPEUTICS MARKET, BY FORM, 2021-2030 (USD MILLION) 52
TABLE 8 INDIA ORAL SOLUTION IN XEROSTOMIA THERAPEUTICS MARKET, BY FORM, 2021-2030 (VOLUME) 52
TABLE 9 INDIA ARTIFICIAL SALIVA IN XEROSTOMIA THERAPEUTICS MARKET, BY BRAND, 2021-2030 (USD MILLION) 53
TABLE 10 INDIA ARTIFICIAL SALIVA IN XEROSTOMIA THERAPEUTICS MARKET, BY BRAND, 2021-2030 (VOLUME) 54
TABLE 11 INDIA DRUGS IN XEROSTOMIA THERAPEUTICS MARKET, BY DRUG, 2021-2030 (USD MILLION) 55
TABLE 12 INDIA DRUGS IN XEROSTOMIA THERAPEUTICS MARKET, BY DRUG, 2021-2030 (VOLUME) 55
TABLE 13 INDIA CHOLINOMIMETIC DRUGS IN XEROSTOMIA THERAPEUTICS MARKET, BY DRUG, 2021-2030 (USD MILLION) 56
TABLE 14 INDIA CHOLINOMIMETIC DRUGS IN XEROSTOMIA THERAPEUTICS MARKET, BY DRUG, 2021-2030 (VOLUME) 56
TABLE 15 INDIA DRUGS IN XEROSTOMIA THERAPEUTICS MARKET, BY DRUG TYPE, 2021-2030 (USD MILLION) 57
TABLE 16 INDIA BRANDED IN XEROSTOMIA THERAPEUTICS MARKET, BY DRUG TYPE, 2021-2030 (USD MILLION) 57
TABLE 17 INDIA BRANDED IN XEROSTOMIA THERAPEUTICS MARKET, BY DRUG TYPE, 2021-2030 (VOLUME) 58
TABLE 18 INDIA XEROSTOMIA THERAPEUTICS MARKET, BY TYPE, 2021-2030 (USD MILLION) 63
TABLE 19 INDIA XEROSTOMIA THERAPEUTICS MARKET, BY MODE OF PURCHASE, 2021-2030 (USD MILLION) 68
TABLE 20 INDIA XEROSTOMIA THERAPEUTICS MARKET, BY POPULATION TYPE, 2021-2030 (USD MILLION) 73
TABLE 21 INDIA XEROSTOMIA THERAPEUTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 78
TABLE 22 INDIA XEROSTOMIA THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 84

LIST OF FIGURES

FIGURE 1 THE INDIA XEROSTOMIA THERAPEUTICS MARKET: SEGMENTATION 16
FIGURE 2 THE INDIA XEROSTOMIA THERAPEUTICS MARKET: DATA TRIANGULATION 18
FIGURE 3 THE INDIA XEROSTOMIA THERAPEUTICS MARKET: DROC ANALYSIS 19
FIGURE 4 THE INDIA XEROSTOMIA THERAPEUTICS MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS 20
FIGURE 5 THE INDIA XEROSTOMIA THERAPEUTICS MARKET: COMPANY RESEARCH ANALYSIS 20
FIGURE 6 THE INDIA XEROSTOMIA THERAPEUTICS MARKET: INTERVIEW DEMOGRAPHICS 22
FIGURE 7 THE INDIA XEROSTOMIA THERAPEUTICS MARKET: DBMR MARKET POSITION GRID 23
FIGURE 8 THE INDIA XEROSTOMIA THERAPEUTICS MARKET: END USER COVERAGE GRID 24
FIGURE 9 THE INDIA XEROSTOMIA THERAPEUTICS MARKET: VENDOR SHARE ANALYSIS 25
FIGURE 10 THE INDIA XEROSTOMIA THERAPEUTICS MARKET: SEGMENTATION 28
FIGURE 11 THE RISING USE OF CHEMOTHERAPY AND RADIOTHERAPY IN THE CANCER TREATMENT IS EXPECTED TO DRIVE THE INDIA XEROSTOMIA THERAPEUTICS MARKET IN THE FORECAST PERIOD 29
FIGURE 12 PRODUCT TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE INDIA XEROSTOMIA THERAPEUTICS MARKET IN 2023 & 2030 29
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF INDIA XEROSTOMIA THERAPEUTICS MARKET 38
FIGURE 14 INDIA XEROSTOMIA THERAPEUTICS MARKET: BY PRODUCT TYPE, 2022 46
FIGURE 15 INDIA XEROSTOMIA THERAPEUTICS MARKET: BY PRODUCT TYPE, 2023-2030 (USD MILLION) 47
FIGURE 16 INDIA XEROSTOMIA THERAPEUTICS MARKET: BY PRODUCT TYPE, CAGR (2023-2030) 47
FIGURE 17 INDIA XEROSTOMIA THERAPEUTICS MARKET: BY PRODUCT TYPE, LIFELINE CURVE 48
FIGURE 18 INDIA XEROSTOMIA THERAPEUTICS MARKET: BY TYPE, 2022 61
FIGURE 19 INDIA XEROSTOMIA THERAPEUTICS MARKET: BY TYPE, 2023-2030 (USD MILLION) 62
FIGURE 20 INDIA XEROSTOMIA THERAPEUTICS MARKET: BY TYPE, CAGR (2023-2030) 62
FIGURE 21 INDIA XEROSTOMIA THERAPEUTICS MARKET: BY TYPE, LIFELINE CURVE 63
FIGURE 22 INDIA XEROSTOMIA THERAPEUTICS MARKET: BY MODE OF PURCHASE ,2022 66
FIGURE 23 INDIA XEROSTOMIA THERAPEUTICS MARKET: BY MODE OF PURCHASE, 2023-2030 (USD MILLION) 67
FIGURE 24 INDIA XEROSTOMIA THERAPEUTICS MARKET: BY MODE OF PURCHASE , CAGR (2023-2030) 67
FIGURE 25 INDIA XEROSTOMIA THERAPEUTICS MARKET: BY MODE OF PURCHASE , LIFELINE CURVE 68
FIGURE 26 INDIA XEROSTOMIA THERAPEUTICS MARKET: BY POPULATION TYPE, 2022 71
FIGURE 27 INDIA XEROSTOMIA THERAPEUTICS MARKET: BY POPULATION TYPE, 2023-2030 (USD MILLION) 72
FIGURE 28 INDIA XEROSTOMIA THERAPEUTICS MARKET: BY POPULATION TYPE, CAGR (2023-2030) 72
FIGURE 29 INDIA XEROSTOMIA THERAPEUTICS MARKET: BY POPULATION TYPE, LIFELINE CURVE 73
FIGURE 30 INDIA XEROSTOMIA THERAPEUTICS MARKET: BY END USER, 2022 76
FIGURE 31 INDIA XEROSTOMIA THERAPEUTICS MARKET: BY END USER, 2023-2030 (USD MILLION) 77
FIGURE 32 INDIA XEROSTOMIA THERAPEUTICS MARKET: BY END USER, CAGR (2023-2030) 77
FIGURE 33 INDIA XEROSTOMIA THERAPEUTICS MARKET: BY END USER, LIFELINE CURVE 78
FIGURE 34 INDIA XEROSTOMIA THERAPEUTICS MARKET: BY DISTRIBUTION CHANNEL, 2022 82
FIGURE 35 INDIA XEROSTOMIA THERAPEUTICS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION) 83
FIGURE 36 INDIA XEROSTOMIA THERAPEUTICS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 83
FIGURE 37 INDIA XEROSTOMIA THERAPEUTICS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 84
FIGURE 38 INDIA XEROSTOMIA THERAPEUTICS MARKET: COMPANY SHARE 2022 (%) 87